Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Merck
US Army
AstraZeneca
Johnson and Johnson
Fuji
UBS
Queensland Health
Covington
Farmers Insurance

Generated: April 26, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 017869

« Back to Dashboard

NDA 017869 describes FUNDUSCEIN-25, which is a drug marketed by Novartis and is included in one NDA. Additional details are available on the FUNDUSCEIN-25 profile page.

The generic ingredient in FUNDUSCEIN-25 is fluorescein sodium. There are five drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the fluorescein sodium profile page.
Summary for 017869
Tradename:FUNDUSCEIN-25
Applicant:Novartis
Ingredient:fluorescein sodium
Patents:0
Formulation / Manufacturing:see details
Medical Subject Heading (MeSH) Categories for 017869

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:INJECTABLE;INJECTIONStrength25% **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:Yes

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
Fish and Richardson
Julphar
Teva
Express Scripts
Dow
Daiichi Sankyo
Citi
Deloitte

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.